Nu-Med Plus (NUMD) Total Current Liabilities (2011 - 2026)
Nu-Med Plus' (NUMD) quarterly Total Current Liabilities came in at $280395.0 in Q2 2026, up 10.02% year-over-year from $254857.0 in Q2 2025, and little changed quarter-over-quarter from $279189.0 in Q4 2025.
Powered by 
Analysis
Nu-Med Plus (NUMD) Total Current Liabilities (2011 - 2026) Analysis & Trends
Nu-Med Plus has disclosed Total Current Liabilities across 16 years of filings, most recently posting $280395.0 for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 10.02% year-over-year to $280395.0; the TTM figure through Jun 2026 stood at $280395.0 (up 10.02% YoY), while the FY2025 annual figure was $279189.0, up 24.38% from the prior year.
- Total Current Liabilities came in at $280395.0 for Q2 2026 at Nu-Med Plus, roughly flat from $279189.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $280395.0 in Q2 2026 to a low of $142570.0 in Q4 2022.
- Average Total Current Liabilities over 5 years is $212078.3, with a median of $211382.0 recorded in 2024.
- Year-over-year, Total Current Liabilities surged 181.47% in 2022 and slumped 46.69% in 2023.
- Over 5 years, Total Current Liabilities stood at $142570.0 in 2022, then gained by 12.37% to $160207.0 in 2023, then surged by 40.11% to $224469.0 in 2024, then grew by 24.38% to $279189.0 in 2025, then advanced by 0.43% to $280395.0 in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $280395.0 in Q2 2026, $279189.0 in Q4 2025, and $263708.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 280,395.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 280,395.00 |
| Dec 31, 2025 | 279,189.00 |
| Sep 30, 2025 | 263,708.00 |
| Jun 30, 2025 | 254,857.00 |
| Mar 31, 2025 | 240,202.00 |
| Dec 31, 2024 | 224,469.00 |
| Sep 30, 2024 | 211,382.00 |
| Jun 30, 2024 | 196,905.00 |
| Mar 31, 2024 | 177,593.00 |
| Dec 31, 2023 | 160,207.00 |
| Sep 30, 2023 | 145,703.00 |
| Jun 30, 2023 | 152,096.00 |
| Mar 31, 2023 | 150,298.00 |
| Dec 31, 2022 | 142,570.00 |
| Sep 30, 2022 | 273,299.00 |
| Jun 30, 2022 | 255,521.00 |
| Mar 31, 2022 | 196,937.00 |
| Dec 31, 2021 | 154,521.00 |
| Sep 30, 2021 | 121,253.00 |
| Jun 30, 2021 | 90,781.00 |